NCT03480243View on ClinicalTrials.gov

Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

August 2, 2018

Study Completion Date

August 2, 2018

Conditions
Pharmacokinetics
Interventions
DRUG

Padsevonil (UCB0942)

"* Pharmaceutical Form: film-coated tablet~* Route of Administration: Oral use"

DRUG

Erythromycin

"* Pharmaceutical Form: film-coated tablet~* Route of Administration: Oral use"

Trial Locations (1)

Unknown

Up0057 001, London

All Listed Sponsors
lead

UCB Biopharma S.P.R.L.

INDUSTRY

NCT03480243 - Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil | Biotech Hunter | Biotech Hunter